These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15377745)

  • 21. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.
    Leuchter AF; Hunter AM; Jain FA; Tartter M; Crump C; Cook IA
    J Psychiatr Res; 2017 Jan; 84():174-183. PubMed ID: 27770740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression.
    Kanekar S; Ettaro R; Hoffman MD; Ombach HJ; Brown J; Lynch C; Sheth CS; Renshaw PF
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma serotonin levels are associated with antidepressant response to SSRIs.
    Holck A; Wolkowitz OM; Mellon SH; Reus VI; Nelson JC; Westrin Å; Lindqvist D
    J Affect Disord; 2019 May; 250():65-70. PubMed ID: 30831543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
    Mallinckrodt CH; Prakash A; Houston JP; Swindle R; Detke MJ; Fava M
    Neuropsychobiology; 2007; 56(2-3):73-85. PubMed ID: 18037817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct Neural-Functional Effects of Treatments With Selective Serotonin Reuptake Inhibitors, Electroconvulsive Therapy, and Transcranial Magnetic Stimulation and Their Relations to Regional Brain Function in Major Depression: A Meta-analysis.
    Chau DT; Fogelman P; Nordanskog P; Drevets WC; Hamilton JP
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 May; 2(4):318-326. PubMed ID: 29560920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.
    Kugaya A; Sanacora G; Staley JK; Malison RT; Bozkurt A; Khan S; Anand A; Van Dyck CH; Baldwin RM; Seibyl JP; Charney D; Innis RB
    Biol Psychiatry; 2004 Oct; 56(7):497-502. PubMed ID: 15450785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of selective serotonin reuptake inhibitor on prefrontal-striatal connectivity is dependent on the level of TNF-α in patients with major depressive disorder.
    Liu K; Zhao X; Lu X; Zhu X; Chen H; Wang M; Yan W; Jing L; Deng Y; Yu L; Wu H; Wen G; Sun X; Lv Z
    Psychol Med; 2019 Nov; 49(15):2608-2616. PubMed ID: 30520409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The serotonin transporter in psychiatric disorders: insights from PET imaging.
    Spies M; Knudsen GM; Lanzenberger R; Kasper S
    Lancet Psychiatry; 2015 Aug; 2(8):743-755. PubMed ID: 26249305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor.
    Fujita M; Richards EM; Niciu MJ; Ionescu DF; Zoghbi SS; Hong J; Telu S; Hines CS; Pike VW; Zarate CA; Innis RB
    Mol Psychiatry; 2017 May; 22(5):754-759. PubMed ID: 27725657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
    Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
    Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SSRI antidepressants do not confound single photon emission computed tomography (SPECT) imaging studies using the alpha4beta2 nicotinic acetylcholine receptor [123I]5-I-A85380 ligand: in vivo and in vitro evidence.
    Cavanagh J; Patterson J; Pimlott S; Wyper D; Dewar D
    Synapse; 2010 Feb; 64(2):111-6. PubMed ID: 19771591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synapse regression in depression: the role of 5-HT receptors in modulating NMDA receptor function and synaptic plasticity.
    Bennett MR
    Aust N Z J Psychiatry; 2010 Apr; 44(4):301-8. PubMed ID: 20307163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach.
    Zobel A; Joe A; Freymann N; Clusmann H; Schramm J; Reinhardt M; Biersack HJ; Maier W; Broich K
    Psychiatry Res; 2005 Aug; 139(3):165-79. PubMed ID: 16043331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder.
    Quilty LC; Meusel LA; Bagby RM
    J Affect Disord; 2008 Nov; 111(1):67-73. PubMed ID: 18384882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome.
    Lundgren JD; Amsterdam J; Newberg A; Allison KC; Wintering N; Stunkard AJ
    Eat Weight Disord; 2009 Mar; 14(1):45-50. PubMed ID: 19367140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder.
    Gray NA; Milak MS; DeLorenzo C; Ogden RT; Huang YY; Mann JJ; Parsey RV
    Biol Psychiatry; 2013 Jul; 74(1):26-31. PubMed ID: 23374637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder.
    Varigonda AL; Jakubovski E; Taylor MJ; Freemantle N; Coughlin C; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):557-64. PubMed ID: 26088660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.